Anthony Daniels, M.D., M.Sc.
- Assistant Professor of Ophthalmology and Visual Sciences
- Assistant Professor of Radiation Oncology
Anthony Daniels, M.D., M.Sc.
- Assistant Professor of Ophthalmology and Visual Sciences
- Assistant Professor of Radiation Oncology
anthony.b.daniels@vumc.org
Research Program
Departments/Affiliations
Provider Information
Profile
Dr. Anthony Daniels is an ocular oncologist and is a member of the Vanderbilt Eye Institute and of the Vanderbilt-Ingram Cancer Center. He graduated summa cum laude from Princeton University and subsequently received a Master's degree in public health policy from the London School of Economics. After graduating from the University of Pennsylvania School of Medicine, he completed an internship at the Memorial Sloan-Kettering Cancer Center, and both his ophthalmology residency as well as a retina surgery fellowship at Harvard Medical School/Massachusetts Eye & Ear Infirmary. He subsequently pursued additional tumor training at Memorial Sloan Kettering Cancer Center and at the Mayo Clinic.
Dr. Daniels specializes in intraocular cancers in adults and children, including melanoma, retinoblastoma, ocular metastases and leukemia/lymphoma. He also specializes in benign tumors inside the eye that can threaten vision, including retinal capillary hemangiomas that can be associated with von Hippel-Lindau syndrome, hamartomas, osteomas, and others. In addition, he treats side effects associated with radiation therapy to the eye.
He has been nationally recognized for his research, which focuses on minimizing complications associated with eye cancer treatment and in understanding and preventing the spread of cancer cells from the eye to the rest of the body. Dr. Daniels was awarded the Ronald G. Michels Award, given to the top retina fellows in the country, as well as the Ronald Margherio Research Award from the Retina Society. He is a Diplomate of the American Board of Ophthalmology. He has authored an ophthalmology textbook, as well as more than 20 peer reviewed papers and book chapters, and has received more than a dozen research awards.
Education
- M.D., University of Pennsylvania, Philadelphia, Pennsylvania (2007)
- M.S.H.S., London School of Economics, London, United Kingdom (2003)
- B.A., Princeton University, Princeton, New Jersey (2002)
Postgraduate Training
- Vitreoretinal Surgery Fellowship, Harvard Medical School Department of Ophthalmology, Massachusetts Eye & Ear Infirmary, Boston, MA (7/2011 - 7/2013)
- Ophthalmology Residency Training Program, Harvard Medical School Residency Program in Ophthalmology, Massachusetts Eye & Ear Infirmary, Boston, MA (7/2008 - 6/2011)
- Transitional Year Internship Program, Memorial Sloan Kettering Cancer Center, New York, NY (6/2007 - 6/2008)
Research Emphasis
Research Description
Publications
- Johnson DB, Daniels AB. Continued Poor Survival in Metastatic Uveal Melanoma: Implications for Molecular Prognostication, Surveillance Imaging, Adjuvant Therapy, and Clinical Trials. JAMA Ophthalmol [print-electronic]. 2018 Jun 6/28/2018; PMID: 29955760, PII: 2686114, DOI: 10.1001/jamaophthalmol.2018.1813, ISSN: 2168-6173.
- Braue JA, Daniels AB, Zwerner JP, Kim SJ, Zic JA. Intraocular involvement of mycosis fungoides associated with immunophenotypic switch from CD4+ to CD8 [letter]. Blood [print-electronic]. 2018 Feb 2/22/2018; 131(8): 932-5. PMID: 29298755, PMCID: PMC5824338, PII: blood-2017-11-814194, DOI: 10.1182/blood-2017-11-814194, ISSN: 1528-0020.
- Arreola A, Payne LB, Julian MH, de Cubas AA, Daniels AB, Taylor S, Zhao H, Darden J, Bautch VL, Rathmell WK, Chappell JC. Von Hippel-Lindau mutations disrupt vascular patterning and maturation via Notch. JCI Insight [print-electronic]. 2018 Feb 2/22/2018; 3(4): PMID: 29467323, PMCID: PMC5916240, PII: 92193, DOI: 10.1172/jci.insight.92193, ISSN: 2379-3708.
- Daniels AB, Froehler MT, Pierce JM, Nunnally AH, Calcutt MW, Bridges TM, LaNeve DC, Williams PE, Boyd KL, Reyzer ML, Lindsley CW, Friedman DL, Richmond A. Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma. Invest. Ophthalmol. Vis. Sci. 2018 Jan 1/1/2018; 59(1): 446-54. PMID: 29368001, PMCID: PMC5783625, PII: 2670512, DOI: 10.1167/iovs.17-22302, ISSN: 1552-5783.
- Ling J, Tauscher R, Mehta V, Zhang M, Daniels A, Kohanim S. The Role for Sentinel Lymph Node Biopsy in the Management of Conjunctival Melanoma. Int Ophthalmol Clin. 2017; 57(1): 87-101. PMID: 27898616, PII: 00004397-201705710-00008, DOI: 10.1097/IIO.0000000000000161, ISSN: 1536-9617.
- Yuan S, Friedman DL, Daniels AB. Evolution of Chemotherapy Approaches for the Treatment of Intraocular Retinoblastoma: A Comprehensive Review. Int Ophthalmol Clin. 2017; 57(1): 117-28. PMID: 27898618, PII: 00004397-201705710-00010, DOI: 10.1097/IIO.0000000000000155, ISSN: 1536-9617.
- Batson SA, Breazzano MP, Milam RW, Shinohara E, Johnson DB, Daniels AB. Rationale for Harnessing the Abscopal Effect as Potential Treatment for Metastatic Uveal Melanoma. Int Ophthalmol Clin. 2017; 57(1): 41-8. PMID: 27898612, PII: 00004397-201705710-00004, DOI: 10.1097/IIO.0000000000000152, ISSN: 1536-9617.
- Hollar MW, Zhang MM, Daniels A, Kohanim S. Mechanisms Underlying the Absence of Cancers of the Human Crystalline Lens. Int Ophthalmol Clin. 2017; 57(1): 49-56. PMID: 27898613, PII: 00004397-201705710-00005, DOI: 10.1097/IIO.0000000000000159, ISSN: 1536-9617.
- Nichols EE, Richmond A, Daniels AB. Micrometastatic Dormancy in Uveal Melanoma: A Comprehensive Review of the Evidence, Mechanisms, and Implications for Future Adjuvant Therapies. Int Ophthalmol Clin. 2017; 57(1): 1-10. PMID: 27898609, PII: 00004397-201705710-00001, DOI: 10.1097/IIO.0000000000000160, ISSN: 1536-9617.
- Milam RW, Batson SA, Breazzano MP, Ayala-Peacock DN, Daniels AB. Modern and Novel Radiotherapy Approaches for the Treatment of Uveal Melanoma. Int Ophthalmol Clin. 2017; 57(1): 11-27. PMID: 27898610, PII: 00004397-201705710-00002, DOI: 10.1097/IIO.0000000000000153, ISSN: 1536-9617.
- Breazzano MP, Milam RW, Batson SA, Johnson DB, Daniels AB. Immunotherapy for Uveal Melanoma. Int Ophthalmol Clin. 2017; 57(1): 29-39. PMID: 27898611, PII: 00004397-201705710-00003, DOI: 10.1097/IIO.0000000000000148, ISSN: 1536-9617.
- Yuan S, Friedman DL, Daniels AB. Alternative Chemotherapeutic Agents for the Treatment of Retinoblastoma Using the Intra-Arterial and Intravitreal Routes: A Path Forward Toward Drug Discovery. Int Ophthalmol Clin. 2017; 57(1): 129-41. PMID: 27898619, PII: 00004397-201705710-00011, DOI: 10.1097/IIO.0000000000000154, ISSN: 1536-9617.
- Daniels AB, Mukai S. Modern Surgical Techniques in the Management of Retinoblastoma. Int Ophthalmol Clin. 2017; 57(1): 195-218. PMID: 27898624, PII: 00004397-201705710-00016, DOI: 10.1097/IIO.0000000000000151, ISSN: 1536-9617.
- Scelfo C, Francis JH, Khetan V, Jenkins T, Marr B, Abramson DH, Shields CL, Pe'er J, Munier F, Berry J, Harbour JW, Yarovoy A, Lucena E, Murray TG, Bhagia P, Paysse E, Tuncer S, Chantada GL, Moll AC, Ushakova T, Plager DA, Ziyovuddin I, Leal CA, Materin MA, Ji XD, Cursino JW, Polania R, Kiratli H, All-Ericsson C, Kebudi R, Honavar SG, Vishnevskia-Dai V, Epelman S, Daniels AB, Ling JD, Traore F, Ramirez-Ortiz MA. An international survey of classification and treatment choices for group D retinoblastoma. Int J Ophthalmol. 2017; 10(6): 961-7. PMID: 28730089, PMCID: PMC5515152, PII: ijo-10-06-961, DOI: 10.18240/ijo.2017.06.20, ISSN: 2222-3959.
